Global Automated Breast Ultrasound System (ABUS) Market Size By Type (Automated Breast Ultrasound System, Automated Breast Volume Scanner), By Application (Hospitals, Diagnostic Imaging Centers), By R...

The Global Automated Breast Ultrasound System (ABUS) Market was valued at USD 1.2 billion in 2023 and is projected to surpass USD 2.8 billion by 2031, growing at a CAGR of 11.4% during the forecast period of 2023-2031. The rising incidence of breast cancer, increasing awareness regarding early detection, and technological advancements in ultrasound imaging are key factors driving market growth. Automated breast ultrasound systems provide enhanced imaging capabilities compared to traditional hand-held ultrasound (HHUS), making them increasingly preferred for dense breast tissue screening.

Market Drivers

Rising Breast Cancer Prevalence

The increasing global incidence of breast cancer is a significant factor fueling the demand for ABUS. According to the World Health Organization (WHO), breast cancer is the most common cancer among women worldwide, necessitating improved screening and diagnostic techniques.

Technological Advancements in Ultrasound Imaging

Ongoing advancements, such as 3D automated ultrasound technology, artificial intelligence (AI)-integrated imaging, and improved workflow efficiency, are driving the adoption of ABUS. These innovations enhance detection rates, reduce operator dependency, and provide consistent, high-quality imaging.

Growing Awareness and Government Initiatives

Numerous government initiatives and non-profit organizations worldwide are promoting breast cancer awareness and early detection. Funding for breast imaging technologies and mandatory breast density notification laws in regions like the U.S. are boosting ABUS adoption.

Market Restraints

High Cost of ABUS Equipment

The high initial cost of purchasing ABUS systems, along with maintenance expenses, poses a challenge for small healthcare facilities and diagnostic centers, limiting market penetration.

Lack of Skilled Professionals

Despite automation, trained radiologists are required to interpret ABUS scans accurately. A shortage of skilled ultrasound professionals, particularly in developing countries, could hinder market growth.

Market Opportunities

Rising Adoption of AI in Breast Imaging

The integration of artificial intelligence (AI) in ABUS for automated lesion detection, image enhancement, and predictive analytics presents significant growth opportunities. AI-driven ABUS solutions help radiologists detect breast cancer with greater accuracy, reducing false positives and improving efficiency.

Expansion in Emerging Markets

Emerging economies, including India, China, and Brazil, present lucrative growth opportunities due to increasing healthcare investments, improved healthcare infrastructure, and rising awareness of early breast cancer detection.

Market by System Type Insights

Based on system type, the Standalone ABUS segment accounted for the largest market share in 2023. Standalone systems offer high-resolution imaging with advanced AI-based detection, making them a preferred choice in hospitals and diagnostic centers. The Portable ABUS segment is expected to grow at the fastest rate, driven by the increasing demand for point-of-care imaging and home-based screening.

Market by End-Use Insights

Hospitals and Diagnostic Centers Lead the Market

Hospitals and diagnostic imaging centers accounted for over 65% of the market share in 2023, driven by their large patient base and access to advanced imaging technologies. ABUS is increasingly used as an adjunct to mammography, especially for women with dense breast tissue.

Rising Adoption in Ambulatory Surgical Centers (ASCs)

Ambulatory surgical centers (ASCs) are witnessing growing adoption of ABUS due to the increasing preference for outpatient diagnostic procedures, reducing the burden on hospitals.

Market by Regional Insights

North America Dominates the Market

North America held the largest share of the ABUS market in 2023, attributed to high breast cancer screening rates, strong healthcare infrastructure, and favorable reimbursement policies. The U.S. remains the primary market driver with its stringent breast density notification laws.

Asia-Pacific to Witness the Fastest Growth

Asia-Pacific is projected to register the highest CAGR during the forecast period. Rising healthcare expenditures, increasing awareness campaigns, and the expansion of healthcare facilities in China, Japan, and India are driving ABUS adoption in the region.

Europe Holds a Significant Share

European countries, including Germany, France, and the U.K., have well-established breast cancer screening programs, contributing to steady ABUS market growth.

Competitive Scenario

Key players operating in the Global Automated Breast Ultrasound System (ABUS) Market include:

GE Healthcare

Siemens Healthineers

Koninklijke Philips N.V.

Hitachi, Ltd.

SonoCine, Inc.

Delphinus Medical Technologies

Hologic, Inc.

iVu Imaging Corporation

These companies focus on product innovation, strategic collaborations, and AI-powered imaging solutions to strengthen their market presence.

Scope of Work – Global Automated Breast Ultrasound System (ABUS) Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.8 billion

CAGR (2023-2031) 11.4%

Key Segments by System Type Standalone ABUS, Portable ABUS

Key Segments by End-Use Hospitals, Diagnostic Centers, ASCs

Leading Region North America

Key Players GE Healthcare, Siemens Healthineers, Philips, Hologic, Hitachi

Key Market Developments

February 2024: GE Healthcare launched an AI-powered ABUS system with real-time lesion detection to improve breast cancer screening accuracy.

November 2023: Siemens Healthineers introduced an upgraded ABUS solution integrated with machine learning algorithms for enhanced diagnostic efficiency.

September 2023: Hologic, Inc. expanded its breast imaging portfolio by acquiring a startup specializing in AI-based breast ultrasound diagnostics.

July 2023: Philips partnered with leading hospitals in the U.K. to deploy ABUS technology for routine breast cancer screening in high-risk populations.

FAQs

1. What is the current market size of the Global Automated Breast Ultrasound System (ABUS) Market?

The market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.8 billion by 2031.

2. What is the major growth driver of the Global ABUS Market?

The primary growth driver is the rising prevalence of breast cancer and increasing demand for early detection technologies.

3. Which is the largest region during the forecast period in the Global ABUS Market?

North America is expected to remain the largest market due to its advanced healthcare infrastructure and high adoption of breast imaging technologies.

4. Which segment accounted for the largest market share in the Global ABUS Market?

The Standalone ABUS segment accounted for the largest share in 2023, driven by its advanced imaging capabilities.

5. Who are the key market players in the Global ABUS Market?

Key players include GE Healthcare, Siemens Healthineers, Philips, Hologic, Hitachi, and SonoCine, Inc., among others.

This report provides a comprehensive analysis of the Global Automated Breast Ultrasound System (ABUS) Market, highlighting growth trends, market drivers, regional insights, and competitive landscape to help stakeholders make informed decisions.